Chengdu, China

Hanwen Deng

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.1

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hanwen Deng: Innovator in Bioactive Molecule Conjugates

Introduction

Hanwen Deng is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of bioactive molecule conjugates. With a total of 4 patents, his work focuses on innovative methods for treating diseases associated with abnormal cell activity.

Latest Patents

Deng's latest patents include groundbreaking advancements in bioactive molecule conjugates. One of his notable inventions is a patent for a bioactive molecule conjugate, preparation method, and its use. This invention details improved coupling methods for drug and targeting moieties, specifically for antibody-drug conjugates and small molecule drug conjugates. These conjugates are designed for the treatment of diseases linked to abnormal cell activity. Another significant patent involves a cytotoxin and conjugate, which outlines a method for modifying chimeric antigen receptor-modified T cells (CAR-T cells). This method enables the CAR-T cells to specifically recognize and bind to tumor cells with elevated expression of the ROBO1 protein, providing a potential treatment for tumor-related diseases.

Career Highlights

Throughout his career, Hanwen Deng has worked with notable companies in the biopharmaceutical sector, including Sichuan Kelun Biotech Biopharmaceutical Co., Ltd. and Sichuan Kelun Biotech Biopharmaceuticals Co., Ltd. His expertise in the field has positioned him as a key player in the development of innovative therapeutic solutions.

Collaborations

Deng has collaborated with several professionals in his field, including Jiaqiang Cai and Shuai Song. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hanwen Deng's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work in bioactive molecule conjugates is paving the way for new treatment options for diseases associated with abnormal cell activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…